Progenics Stock Soars (PGNX)

NEW YORK ( TheStreet) -- Shares of Progenics Pharmaceuticals (Nasdaq: PGNX) have taken a tremendous swing upward. The stock is trading at $6.72 as of 4 p.m. ET, 20.9% above Tuesday's closing price of $5.56. Volume is at 276,304, 2.5 times the daily average of 111,300.

Progenics has a market cap of $169.8 million and is part of the health care sector and drugs industry. Shares are up 1.8% year to date as of the close of trading on Tuesday.

Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases in the United States and internationally. The company has a P/E ratio of 91.7, below the average drugs industry P/E ratio of 125.8 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Progenics as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full Progenics Ratings Report.

See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.

Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.

null

More from Markets

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens